Posted inBiotechnology
Exploring AI’s Impact on Consumer Behavior Insights
In an ever-evolving digital landscape, the intersection of artificial intelligence (AI) and consumer behavior is emerging as a crucial domain…
Posted inBiotechnology
Breakthroughs in Treating Localized Bladder Cancer
Bladder cancer continues to pose a formidable challenge to global healthcare systems, remaining a prevalent malignancy with significant morbidity and…
Posted inBiotechnology
Pfizer charts course to tumor-selective antigens in $865M Cartography collab
Pfizer is penning a cancer discovery pact with Cartography Biosciences that could max out at $865 million biobucks. The Big…
Posted inBiotechnology
Gilead garners lipid package for cancer asset in $300M research pact
Gilead Sciences has found a shiny new package for one of its cancer assets, inking a research pact worth up…
Posted inGenetics
CHANGE-seq-BE Developed to Allow Scientists to Better Understand Base Editors
Scientists at St. Jude Children’s Research Hospital report that they have developed an unbiased, sensitive, and resource-efficient method to identify…
Posted inBiotechnology
Targeting GASDERMIN D in TAU-related frontotemporal dementia
In recent years, the landscape of neurodegenerative diseases has undergone transformative changes, particularly in our understanding of frontotemporal dementia (FTD).…
Posted inBiotechnology
Antibiotic Resistance Patterns in Pediatric Cancer Patients
In a groundbreaking study published in BMC Pediatrics, researchers have tackled a significant health concern affecting one of the most…
Posted inBiotechnology
Transforming Cellulose: Innovations and Applications Unveiled
Cellulose, one of nature’s most abundant biopolymers, serves an essential role in the structural integrity of plant cell walls. Its…
Posted inBiotechnology
Nurses’ Insights and Practices on Sarcopenia Explored
In a groundbreaking descriptive study, researchers led by M.H. Taani, H. Skuble, and C. Antwi-Boasiako have undertaken a significant evaluation…
Posted inBiotechnology
MetaVia weighs in with 9% loss as dual agonist enters the obesity ring
MetaVia has shared an update on its attempt to crash the obesity party, reporting average weight loss of 9.1% in people…